Arcutis Biotherapeutics Inc.
ARQT | NASDAQ
$28
+$2.04 (+7.86%)
Sep 22, 2026, 2:41 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 3.71M | -11.3M | 17.4M | 7.41M | -15.89M | -25.06M | -10.79M | -41.54M | -52.33M | -35.38M | -66.28M | -44.77M | -70.99M | -80.1M | -72.02M | -107.71M | -67.41M | -64.32M | -71.33M | -56.98M | -42.01M | -36.04M |
Depreciation & Amortization | 1.13M | 562K | 563K | 562K | 410K | 3.13M | 458K | 1.77M | 17K | 358K | 385K | 387K | 386K | 363K | 347K | 282K | 155K | 150K | 136K | 116K | 104K | 98K |
Stock-Based Compensation | 23.45M | 10.69M | 10.06M | 10.04M | 10.49M | 9.78M | 9.39M | 9.78M | 12.52M | 10.03M | 8.76M | 10M | 10.58M | 9.48M | 9.26M | 8.79M | 8.1M | 6.53M | 5.69M | 5.36M | 4.34M | 8.5M |
Other Working Capital | 16.17M | 8.9M | 22.06M | 3.66M | 25.33M | -3.7M | 12.93M | 5.69M | 6.71M | 5.03M | 7.22M | 443K | -4.31M | -7.03M | 1.64M | 7.75M | 458K | -5.62M | 10.44M | 7.15M | 1.36M | -15.58M |
Other Non-Cash Items | 1.03M | 493K | 493K | 181K | 183K | -543K | 1.76M | -897K | -1.06M | -1.17M | 16.82M | -425K | -732K | -1.08M | -1.24M | 29.71M | 747K | 1.09M | 960K | 1.23M | 877K | 696K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -16.33M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -14.44M | 1.79M | -2.33M | -19.94M | 5.13M | -17.69M | -1.57M | -3.8M | -4.27M | -5.44M | 411K | -9.18M | -5.73M | -9.01M | -7.41M | 1.23M | -3.57M | -423K | 12.84M | 9.39M | 856K | -19.46M |
Operating Cash Flow | 14.88M | 2.24M | 26.19M | -1.75M | 324K | -30.38M | -748K | -34.69M | -45.12M | -31.6M | -56.24M | -43.98M | -66.49M | -80.34M | -71.07M | -67.7M | -61.98M | -56.98M | -51.71M | -40.88M | -35.83M | -46.2M |
Capital Expenditures | -158K | n/a | n/a | n/a | -78K | -608K | -5M | -143K | n/a | n/a | -6K | -64K | -276K | -82K | -123K | -22.96M | -80K | -124K | -261K | -137K | -43K | -554K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 62.18M | n/a | n/a | n/a | n/a | 15.45M | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -127.74M | -62.15M | -89.18M | -68.54M | -33.15M | -56.11M | -17.4M | -5.69M | -125.78M | -105.95M | -118.18M | -22.39M | -45.61M | -39.67M | -38.09M | -241.56M | -80.24M | -55.5M | -48.24M | -32.39M | -211.88M | n/a |
Sales Maturities Of Investments | 101.35M | 50.82M | 55M | 43.3M | 60.65M | 68.47M | 57.28M | 90.61M | 63.64M | 77.26M | 56M | 68M | 135M | 147.5M | 80.41M | 67.25M | 132.89M | 70.93M | 72M | 36M | 47M | 62.55M |
Other Investing Acitivies | n/a | n/a | n/a | n/a | -10M | n/a | n/a | n/a | n/a | n/a | -62.18M | n/a | n/a | n/a | n/a | -15.45M | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -26.56M | -11.33M | -34.18M | -25.25M | 17.42M | 11.75M | 34.88M | 84.78M | -62.14M | -28.7M | -62.19M | 45.55M | 89.12M | 107.75M | 42.2M | -197.26M | 52.57M | 15.3M | 23.5M | 3.47M | -164.92M | 62M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 72.35M | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -1M | n/a | n/a | 1.48M | n/a | 395K | -97.41M | 394K | 1.46M | 82K | 388K | 867K | 1.07M | 100K | 962K | 123.4M | 1.13M | 261K | n/a | n/a | n/a | 325K |
Financial Cash Flow | 3.06M | 1.07M | 3.72M | 1.48M | 1.38M | 395K | -97.41M | 394K | 1.46M | 161.76M | 99.29M | 867K | 1.07M | 100K | 962K | 284.99M | 1.13M | 14.72M | 72.88M | 63K | 1.19M | 207.82M |
Net Cash Flow | -8.79M | -8.15M | -4.21M | -25.62M | 19.33M | -18.23M | -63.52M | 50.58M | -105.83M | 101.39M | -19.07M | 2.36M | 23.71M | 27.46M | -27.9M | 20.03M | -8.28M | -26.96M | 44.67M | -37.35M | -199.56M | 223.61M |
Free Cash Flow | 14.72M | 2.24M | 26.19M | -1.75M | 246K | -30.99M | -5.75M | -34.83M | -45.12M | -31.6M | -56.25M | -44.05M | -66.76M | -80.43M | -71.19M | -90.65M | -62.06M | -57.1M | -51.97M | -41.02M | -35.87M | -46.76M |
Adj. Free Cash Flow | -8.73M | -8.45M | 16.13M | -11.79M | -10.24M | -40.77M | -15.14M | -44.62M | -57.64M | -41.63M | -65.01M | -54.05M | -77.34M | -89.91M | -80.45M | -99.44M | -70.16M | -63.63M | -57.66M | -46.38M | -40.21M | -55.26M |
Maintenance CapEx | -158K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -19.86M | -80K | -124K | -136K | -116K | -43K | -98K |
Growth CapEx | n/a | n/a | n/a | n/a | -78K | -608K | -5M | -143K | n/a | n/a | -6K | -64K | -276K | -82K | -123K | -3.1M | n/a | n/a | -125K | -21K | n/a | -456K |
Owner Earnings | 14.72M | 2.24M | 26.19M | -1.75M | 324K | -30.38M | -748K | -34.69M | -45.12M | -31.6M | -56.24M | -43.98M | -66.49M | -80.34M | -71.07M | -87.55M | -62.06M | -57.1M | -51.85M | -41M | -35.87M | -46.3M |
Add to Watchlist
Select watchlists to add or remove ARQT